vs
Side-by-side financial comparison of Sintx Technologies, Inc. (SINT) and SciSparc Ltd. (SPRC). Click either name above to swap in a different company.
SciSparc Ltd. is the larger business by last-quarter revenue ($461.0K vs $290.0K, roughly 1.6× Sintx Technologies, Inc.). Sintx Technologies, Inc. runs the higher net margin — -763.8% vs -2041.6%, a 1277.9% gap on every dollar of revenue. On growth, SciSparc Ltd. posted the faster year-over-year revenue change (-45.1% vs -46.5%).
Sintx Technologies, Inc. is an advanced materials company specializing in R&D and manufacturing of high-performance silicon nitride and other technical ceramic products. It serves key segments including medical implants, aerospace & defense, industrial wear components, and electric vehicle applications, with core markets across North America, Europe and Asia-Pacific.
SciSparc Ltd. is a clinical-stage biopharmaceutical company focused on developing novel therapies for unmet medical needs in the neurological, psychiatric, and gastrointestinal disorder segments. It operates across global biotech markets, leveraging proprietary cannabinoid-based formulation technologies to advance its pipeline of therapeutic candidates.
SINT vs SPRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $290.0K | $461.0K |
| Net Profit | $-2.2M | $-9.4M |
| Gross Margin | 64.8% | 78.1% |
| Operating Margin | -799.3% | -588.5% |
| Net Margin | -763.8% | -2041.6% |
| Revenue YoY | -46.5% | -45.1% |
| Net Profit YoY | -30.7% | -155.8% |
| EPS (diluted) | $-0.50 | $17.92 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $290.0K | — | ||
| Q3 25 | $208.0K | — | ||
| Q2 25 | $151.0K | $461.0K | ||
| Q1 25 | $369.0K | — | ||
| Q4 24 | $542.0K | $466.0K | ||
| Q3 24 | $799.0K | — | ||
| Q2 24 | $859.0K | $840.0K | ||
| Q1 24 | $687.0K | — |
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-3.5M | — | ||
| Q2 25 | $-2.3M | $-9.4M | ||
| Q1 25 | $-2.3M | — | ||
| Q4 24 | $-1.7M | $-3.8M | ||
| Q3 24 | $-6.2M | — | ||
| Q2 24 | $-2.2M | $-3.7M | ||
| Q1 24 | $-886.0K | — |
| Q4 25 | 64.8% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 37.7% | 78.1% | ||
| Q1 25 | 33.3% | — | ||
| Q4 24 | 71.6% | 6.9% | ||
| Q3 24 | 73.7% | — | ||
| Q2 24 | 73.9% | 56.4% | ||
| Q1 24 | 67.5% | — |
| Q4 25 | -799.3% | — | ||
| Q3 25 | -1613.0% | — | ||
| Q2 25 | -1764.9% | -588.5% | ||
| Q1 25 | -645.8% | — | ||
| Q4 24 | -319.6% | -813.1% | ||
| Q3 24 | -802.0% | — | ||
| Q2 24 | -315.5% | -419.9% | ||
| Q1 24 | -465.4% | — |
| Q4 25 | -763.8% | — | ||
| Q3 25 | -1701.4% | — | ||
| Q2 25 | -1535.1% | -2041.6% | ||
| Q1 25 | -621.1% | — | ||
| Q4 24 | -312.7% | -813.9% | ||
| Q3 24 | -780.9% | — | ||
| Q2 24 | -256.6% | -438.0% | ||
| Q1 24 | -129.0% | — |
| Q4 25 | $-0.50 | — | ||
| Q3 25 | $-3.46 | — | ||
| Q2 25 | $-0.91 | $17.92 | ||
| Q1 25 | $-1.29 | — | ||
| Q4 24 | $17.04 | $-8.82 | ||
| Q3 24 | $-6.96 | — | ||
| Q2 24 | $-3.61 | $35.70 | ||
| Q1 24 | $-21.66 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $1.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9M | $-81.0K |
| Total Assets | $9.5M | $5.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | — | ||
| Q3 25 | $6.3M | — | ||
| Q2 25 | $4.3M | $1.5M | ||
| Q1 25 | $6.5M | — | ||
| Q4 24 | $3.6M | $1.5M | ||
| Q3 24 | $4.8M | — | ||
| Q2 24 | $4.6M | $252.0K | ||
| Q1 24 | $5.8M | — |
| Q4 25 | $2.9M | — | ||
| Q3 25 | $4.1M | — | ||
| Q2 25 | $4.0M | $-81.0K | ||
| Q1 25 | $6.1M | — | ||
| Q4 24 | $3.9M | $8.9M | ||
| Q3 24 | $5.6M | — | ||
| Q2 24 | $8.8M | $8.7M | ||
| Q1 24 | $9.9M | — |
| Q4 25 | $9.5M | — | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $9.2M | $5.1M | ||
| Q1 25 | $11.4M | — | ||
| Q4 24 | $9.4M | $10.3M | ||
| Q3 24 | $11.3M | — | ||
| Q2 24 | $15.3M | $10.5M | ||
| Q1 24 | $17.6M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.3M | $-1.9M |
| Free Cash FlowOCF − Capex | $-2.4M | — |
| FCF MarginFCF / Revenue | -822.8% | — |
| Capex IntensityCapex / Revenue | 14.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $-2.5M | — | ||
| Q2 25 | $-2.4M | $-1.9M | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | $-1.1M | $-2.9M | ||
| Q3 24 | $-2.6M | — | ||
| Q2 24 | $-2.2M | $-2.2M | ||
| Q1 24 | $-2.7M | — |
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-2.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-1.4M | — | ||
| Q4 24 | $-1.3M | — | ||
| Q3 24 | $-2.6M | — | ||
| Q2 24 | $-2.6M | $-2.2M | ||
| Q1 24 | $-2.9M | — |
| Q4 25 | -822.8% | — | ||
| Q3 25 | -1250.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -368.6% | — | ||
| Q4 24 | -234.3% | — | ||
| Q3 24 | -323.0% | — | ||
| Q2 24 | -299.7% | -261.7% | ||
| Q1 24 | -423.1% | — |
| Q4 25 | 14.5% | — | ||
| Q3 25 | 40.4% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 16.0% | — | ||
| Q4 24 | 26.9% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 41.8% | 0.1% | ||
| Q1 24 | 25.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
